Outset Medical appoints Brent Lang to board; Director Szyman resigns for Edwards spinoff CEO role

Outset Medical, Inc.

Brent D. Lang appointed to the board effective March 12, 2024, filling vacancy left by Catherine Szyman.
Lang is former Chairman & CEO of Vocera Communications, acquired by Stryker for $3 billion in 2022.
Szyman resigned due to pending role as CEO of Edwards Lifesciences' Critical Care spinoff; no disagreement.
Lang will serve on the Audit Committee and be compensated per Outset's non-employee director policy.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Catherine Szyman

Director

OM · Outset Medical, Inc.

Effective: 2024-03-12
Successor: Brent D. Lang
Filed: March 13, 2024, 7:59 PM ET

On March 8, 2024, Catherine Szyman, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), resigned from the Board in preparation for her pending role as Chief Executive Officer of Edwards Lifesciences’ Critical Care spinoff, with such resignation effective March 12, 2024.

Appointed

Brent D. Lang

Director

OM · Outset Medical, Inc.

Effective: 2024-03-12
Filed: March 13, 2024, 7:59 PM ET

On March 10, 2024, the Board appointed Brent D. Lang as a new member of the Board and as a member of the Audit Committee of the Board, with such appointment effective March 12, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine Szyman resigned as Director at Outset Medical, Inc..

Action: resigned
Role: Director

Exact text from the filing

On March 8, 2024, Catherine Szyman, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), resigned from the Board in preparation for her pending role as Chief Executive Officer of Edwards Lifesciences’ Critical Care spinoff, with such resignation effective March 12, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent D. Lang was appointed as Director at Outset Medical, Inc..

Action: appointed
Role: Director

Exact text from the filing

On March 10, 2024, the Board appointed Brent D. Lang as a new member of the Board and as a member of the Audit Committee of the Board, with such appointment effective March 12, 2024.

View on SEC.gov

Outset Medical, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-030779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.